Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7 Thoracic 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 Breast 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 30 pembrolizumab 24 Magnetic Resonance Spectroscopy 24 Specimen Handling 20 Cetuximab 18 Nivolumab 15 Carboplatin 14 Platinum 12 1,2-diaminocyclohexaneplatinum II citrate 12 Radiotherapy, Intensity-Modulated 11 Radiotherapy 10 Radiation 9 Paclitaxel 9 Docetaxel 8 Biopsy 8 Immunoglobulin G 7 Disulfides 7 Surveys and Questionnaires 6 Ipilimumab 6 atezolizumab 5 Fluorouracil 5 toripalimab 4 dostarlimab 4 cemiplimab 4 cabozantinib 4 Taxes 4 Gemcitabine 4 CTLA-4 Antigen 4 Bevacizumab 4 (225)Ac-DOTA-c(RGDyK) 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Immunotherapy × Head & Neck × 30 days × Clear all

NCT05328024 2026-06-05

IPRICE

Centre Paul Strauss

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡